0

Your Cart is Empty

Topics - Low Dose Naltrexone’s Role in Health Optimization: A Drivers-Based Clinical Framework - The Scale of Use – Targeting System-Level Dysregulation with Low Dose Naltrexone - Women’s Health - When Standard of Care Backfires – The Cost of Disrupting Physiology - Thyroid Function Explained - Mechanisms of Action: 18 and Counting - Low-Dose Naltrexone: Health Span & Weight Loss - Ultra-Low Dose Naltrexone - Therapeutic Plasma Exchange: A Modern Solution - Parkinson’s Disease - Endorphin Deficiency and the LDN Sweet Spot - Hashimoto’s Thyroiditis - CRPS - Female Infertility - Peptide Therapy -Targeting Immune Dysfunction - TBI, PCS, PTSD & Cognitive Decline

Recorded Speakers

Angus Dalgleish, MD, FRCP, FRCPath

Find out more

Marina Straszak-Suri, MD, FRCSC

Find out more

Dr. Yusuf (JP) Saleeby, MD

Find out more

Sebastian Denison, BScPharm, RPh

Find out more

Sarah J. Zielsdorf MD, MS, ABIM, IFMCP

Find out more

Yoon Hang Kim, MD, MPH

Find out more

Cory Tichauer, ND

FIND OUT MORE

Elizabeth Livengood, NMD

FIND OUT MORE

Jim Hrncir, RPh, FAPC

Find out more

Stefanie Werner, NMD

FIND OUT MORE

Nat Jones, RPh, FAPC

FIND OUT MORE

Pamela Wartian Smith, MD, MPH, MS

FIND OUT MORE

Samantha Lebsock, PharmD

Find out more

Sajad Zalzala, M.D.

FIND OUT MORE